By combining single-cell transcriptomics, proteomics, phosphoproteomics, and functional validation in PDO/PDX models, we bridge the knowledge gap surrounding BAG5-mediated tumor pathways in NSCLC and provide novel insights with translational implications. The gene discussed is BAG5; the disease is neoplasm.